有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | butyl (2R)-2-[(4-oxo-6-propyl-1H-pyrimidin-2-yl)sulfanyl]propanoate | —— | C14H22N2O3S |
|
—— | methyl (2R)-2-[(4-oxo-6-propyl-1H-pyrimidin-2-yl)sulfanyl]hexanoate | —— | C14H22N2O3S |
|
—— | propyl (2S)-2-[(4-phenyl-5-sulfanylidene-1,3,4-thiadiazol-2-yl)sulfanyl]propanoate | —— | C14H16N2O2S3 |
|
—— | butyl (2S)-2-[[5-(cyclohexylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]propanoate | —— | C15H25N3O2S2 |
|
—— | methyl (2S)-2-[(4-phenyl-5-sulfanylidene-1,3,4-thiadiazol-2-yl)sulfanyl]hexanoate | —— | C15H18N2O2S3 |
|
—— | butyl (2S)-2-[(5-methyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]propanoate | —— | C13H21N3O2S |
|
—— | butyl (2S)-2-[(4-phenyl-5-sulfanylidene-1,3,4-thiadiazol-2-yl)sulfanyl]propanoate | —— | C15H18N2O2S3 |
|
—— | propyl (2R)-2-[(4-oxo-6-propyl-1H-pyrimidin-2-yl)sulfanyl]propanoate | —— | C13H20N2O3S |
|
—— | methyl (2R)-2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]hexanoate | —— | C9H15N3O2S2 |
|
—— | methyl (2S)-2-[(4-oxo-6-propyl-1H-pyrimidin-2-yl)sulfanyl]hexanoate | —— | C14H22N2O3S |
|
—— | butyl (2S)-2-(1-methyltetrazol-5-yl)sulfanylpropanoate | —— | C9H16N4O2S |
|
—— | 5-but-2-ynylsulfanyl-N-[[(2S)-oxolan-2-yl]methyl]-1,3,4-thiadiazol-2-amine | —— | C11H15N3OS2 |
|
—— | (3S,5S)-1-[5-but-2-ynylsulfanyl-4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]-3,5-dimethylpiperidine | —— | C18H24N4OS |
|
—— | propyl (2R)-2-[(5-methyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]propanoate | —— | C12H19N3O2S |
|
—— | methyl (2S)-2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]hexanoate | —— | C9H15N3O2S2 |
|
—— | propyl (2S)-2-[[5-(cyclohexylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]propanoate | —— | C14H23N3O2S2 |
|
—— | 5-(5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-yl)-1H-imidazole | —— | C10H10N2S2 |
|
—— | butyl (2R)-2-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]propanoate | —— | C15H21N3O2S2 |
|
—— | propyl (2S)-2-[(5-methyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]propanoate | —— | C12H19N3O2S |
|
—— | propyl (2S)-2-[[5-(2-methylfuran-3-yl)-4-prop-2-enyl-1,2,4-triazol-3-yl]sulfanyl]propanoate | —— | C16H21N3O3S |
|
—— | propyl (2S)-2-(1-methyltetrazol-5-yl)sulfanylpropanoate | —— | C8H14N4O2S |
|
—— | 3-[(1-Methylpyrrolidin-2-yl)methylsulfanyl]pyridine | —— | C11H16N2S |
|
—— | propyl (2S)-2-[(4-oxo-6-propyl-1H-pyrimidin-2-yl)sulfanyl]propanoate | —— | C13H20N2O3S |
|
—— | butyl (2R)-2-(1-methyltetrazol-5-yl)sulfanylpropanoate | —— | C9H16N4O2S |
|
—— | propyl (2R)-2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]propanoate | —— | C15H19N3O2S2 |
|
—— | butyl (2S)-2-[(4-oxo-6-propyl-1H-pyrimidin-2-yl)sulfanyl]propanoate | —— | C14H22N2O3S |
|
—— | butyl (2S)-2-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]propanoate | —— | C15H21N3O2S2 |
|
—— | 1-[5-but-2-ynylsulfanyl-4-[[(2S)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]-4-methylpiperidine | —— | C17H26N4OS |
|
—— | 5-[(4-chlorophenyl)methyl]-3-[(5-methylthiophen-2-yl)methylsulfanyl]-1H-1,2,4-triazole | —— | C15H14ClN3S2 |
|
—— | 2-but-2-ynylsulfanyl-5-[(2R)-2-phenylpropyl]-1,3,4-oxadiazole | —— | C15H16N2OS |
|
—— | 3-but-2-ynylsulfanyl-4-[[(2S)-oxolan-2-yl]methyl]-1H-1,2,4-triazol-5-one | —— | C11H15N3O2S |
|
—— | propyl (2R)-2-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]propanoate | —— | C14H19N3O2S2 |
|
—— | propyl (2S)-2-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]propanoate | —— | C14H19N3O2S2 |
|
—— | 5-but-2-ynylsulfanyl-1-[[(2R)-oxolan-2-yl]methyl]tetrazole | —— | C10H14N4OS |
|
—— | 3-but-2-ynylsulfanyl-4-[[(2R)-oxolan-2-yl]methyl]-1H-1,2,4-triazol-5-one | —— | C11H15N3O2S |
|
—— | (3R,5R)-1-[5-but-2-ynylsulfanyl-4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]-3,5-dimethylpiperidine | —— | C18H24N4OS |
|
—— | (3S,5R)-1-[5-but-2-ynylsulfanyl-4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]-3,5-dimethylpiperidine | —— | C18H24N4OS |
|
—— | 1-[5-but-2-ynylsulfanyl-4-[[(2R)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]-4-methylpiperidine | —— | C17H26N4OS |
|
—— | 3,5-dimethyl-N-phenyl-4-pyrimidin-2-ylsulfanylpyrazole-1-carboxamide | —— | C16H15N5OS |
|
—— | 2-but-2-ynylsulfanyl-5-[(2S)-2-phenylpropyl]-1,3,4-oxadiazole | —— | C15H16N2OS |
|
—— | 5-but-2-ynylsulfanyl-1-[[(2S)-oxolan-2-yl]methyl]tetrazole | —— | C10H14N4OS |
|
—— | 3-[(3S)-1-azabicyclo[2.2.1]heptan-3-yl]-4-(3-phenylpropylsulfanyl)-1,2,5-thiadiazole | —— | C17H21N3S2 |
|
—— | N,N-dimethyl-4-[[3-(pyridin-2-ylmethylsulfanyl)-1H-1,2,4-triazol-5-yl]methyl]aniline | —— | C17H19N5S |
|
—— | N,N-dimethyl-4-[[3-(thiophen-3-ylmethylsulfanyl)-1H-1,2,4-triazol-5-yl]methyl]aniline | —— | C16H18N4S2 |
|
—— | 7-methyl-4-[(4-methylphenyl)thio]thieno[3,2-d]pyrimidine-6-carboxamide | —— | C15H13N3OS2 |
|
—— | (2R,4R)-2-amino-4-[3-(hydroxymethyl)-6-methylpyridin-2-yl]sulfanyl-4-phenylbutan-1-ol | —— | C17H22N2O2S |
|
—— | 3-(6-Pyridin-4-ylsulfanylpyridin-3-yl)-3,9-diazabicyclo[4.2.1]nonane | —— | C17H20N4S |
|
—— | 2-amino-4-benzylsulfanyl-6-furan-2-yl-pyrimidine-5-carbonitrile | —— | C16H12N4OS |
|
—— | exo-6-(3-(3-hydroxypropylthio)-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane | —— | C12H19N3OS2 |
|
—— | 3-(5-Benzylsulfanylthiophen-2-yl)pyridine | —— | C16H13NS2 |
|